Trial Objectives

The purpose of this study is to learn how interstitial lung disease (ILD) develops and progresses over time in people with early rheumatoid arthritis (RA). There is evidence that RA starts in the lungs in a subset of patients and through this study researchers will be looking at the relationship between your RA and your lungs.

Who Can Participate

Adults diagnosed with rheumatoid arthritis within the last two years may be eligible to participate.

Age: 18-90 Gender: Any

Estimated Time Commitment

5 in-person visits over 18 months

Payment & Reimbursement

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Faduma Ahmed
303.398.1285

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Boehringer Ingelheim

Principal Investigators

Joshua J. Solomon

Joshua J. Solomon, MD

Co-Investigators

Michael P. Mohning

Michael P. Mohning, MD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health